Enregistré dans:
| Format: | Artículo Open Access |
|---|---|
| Publié: |
Wiley
2026
|
| Sujets: | |
| Accès en ligne: | https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70521 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘ eCGM ’ compliance status
par: Chantal Mathieu, et autres
Publié: (2024)
par: Chantal Mathieu, et autres
Publié: (2024)
Comment to ‘Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—“ eCGM ”’
par: Ohad Cohen, et autres
Publié: (2025)
par: Ohad Cohen, et autres
Publié: (2025)
Proposed minimum requirements for market approval of continuous glucose monitoring ( CGM ) systems: A viewpoint from the IFCC working group on CGM
par: Stefan Pleus, et autres
Publié: (2025)
par: Stefan Pleus, et autres
Publié: (2025)
Contributions of intermittently scanned continuous glucose monitoring frequency and bolus insulin dosing on time in range: Analysis of data from CGM and connected insulin pens
par: Pratik Choudhary, et autres
Publié: (2025)
par: Pratik Choudhary, et autres
Publié: (2025)
Diabetes screening in dialysis populations with a glucose challenge test and continuous glucose monitoring— DIGEST study
par: L. Depoorter, et autres
Publié: (2025)
par: L. Depoorter, et autres
Publié: (2025)
Perioperative use and accuracy of continuous glucose monitoring: A systematic review
par: Léa Carlier, et autres
Publié: (2025)
par: Léa Carlier, et autres
Publié: (2025)
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
par: Satish K. Garg, et autres
Publié: (2024)
par: Satish K. Garg, et autres
Publié: (2024)
Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia
par: Lukas van Baal, et autres
Publié: (2025)
par: Lukas van Baal, et autres
Publié: (2025)
Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
par: Yunxiao Wu, et autres
Publié: (2026)
par: Yunxiao Wu, et autres
Publié: (2026)
The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case–control study
par: Riemer A. Been, et autres
Publié: (2025)
par: Riemer A. Been, et autres
Publié: (2025)
Cost‐effectiveness analysis of Dexcom ONE + real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
par: Ryan G. Paul, et autres
Publié: (2026)
par: Ryan G. Paul, et autres
Publié: (2026)
Heterogeneity of continuous glucose monitoring features and their clinical associations in a type 2 diabetes population
par: Elizabeth Healey, et autres
Publié: (2025)
par: Elizabeth Healey, et autres
Publié: (2025)
Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
par: Xiaopeng Shao, et autres
Publié: (2024)
par: Xiaopeng Shao, et autres
Publié: (2024)
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring
par: John S. Pemberton, et autres
Publié: (2026)
par: John S. Pemberton, et autres
Publié: (2026)
Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes
par: Ananthi Anandhakrishnan, et autres
Publié: (2024)
par: Ananthi Anandhakrishnan, et autres
Publié: (2024)
CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
par: Roland H. Stimson, et autres
Publié: (2025)
par: Roland H. Stimson, et autres
Publié: (2025)
The role of real‐time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management
par: Monika Reddy, et autres
Publié: (2024)
par: Monika Reddy, et autres
Publié: (2024)
Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
par: Howard Wolpert, et autres
Publié: (2025)
par: Howard Wolpert, et autres
Publié: (2025)
Differential effects of lifestyle interventions on continuous glucose monitoring metrics in persons with type 2 diabetes: Potential for personalised treatment
par: Iris M. de Hoogh, et autres
Publié: (2025)
par: Iris M. de Hoogh, et autres
Publié: (2025)
Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
par: Irl B. Hirsch, et autres
Publié: (2024)
par: Irl B. Hirsch, et autres
Publié: (2024)
Real‐world evidence for computerized insulin dose‐adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians
par: Mayer B. Davidson, et autres
Publié: (2024)
par: Mayer B. Davidson, et autres
Publié: (2024)
Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
par: Heejun Son, et autres
Publié: (2025)
par: Heejun Son, et autres
Publié: (2025)
Workplace‐based continuous glucose monitoring with structured education for pre‐diabetes and type 2 diabetes: A prospective community cohort study
par: Ji‐Hee Ko, et autres
Publié: (2025)
par: Ji‐Hee Ko, et autres
Publié: (2025)
Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
par: Rui Sun, et autres
Publié: (2025)
par: Rui Sun, et autres
Publié: (2025)
The challenge of assessing impaired awareness of hypoglycaemia in diabetes in the era of continuous glucose monitoring: A narrative review of evidence and translation into clinical practice
par: Simon A. Berry, et autres
Publié: (2025)
par: Simon A. Berry, et autres
Publié: (2025)
Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
par: Juan P. Frías, et autres
Publié: (2025)
par: Juan P. Frías, et autres
Publié: (2025)
Most hospitalised patients with type 2 diabetes benefit from continuous glucose monitoring compared to point‐of‐care glucose testing in a non‐intensive care unit setting: A heterogeneity of treatment effect analysis
par: Mikkel Thor Olsen, et autres
Publié: (2025)
par: Mikkel Thor Olsen, et autres
Publié: (2025)
Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
par: Cecilie H. Svensson, et autres
Publié: (2024)
par: Cecilie H. Svensson, et autres
Publié: (2024)
Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study
par: Harshal Deshmukh, et autres
Publié: (2024)
par: Harshal Deshmukh, et autres
Publié: (2024)
Long‐term effects of continuous glucose monitoring on glycaemic control: Real‐world evidence in a general adult population with type 1 diabetes in Norway
par: Bjørn O. Åsvold, et autres
Publié: (2025)
par: Bjørn O. Åsvold, et autres
Publié: (2025)
Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
par: Line Davidsen, et autres
Publié: (2025)
par: Line Davidsen, et autres
Publié: (2025)
Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA 1c
par: Guangxin Han, et autres
Publié: (2025)
par: Guangxin Han, et autres
Publié: (2025)
Somatic and mental symptoms associated with dysglycaemia, diabetes‐related complications and mental conditions in people with diabetes: Assessments in daily life using continuous glucose monitoring and ecological momentary assessment
par: Norbert Hermanns, et autres
Publié: (2024)
par: Norbert Hermanns, et autres
Publié: (2024)
Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study
par: Michela Vergani, et autres
Publié: (2025)
par: Michela Vergani, et autres
Publié: (2025)
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
par: Stefano Del Prato, et autres
Publié: (2024)
par: Stefano Del Prato, et autres
Publié: (2024)
Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial
par: Emmanuel Ssemmondo, et autres
Publié: (2024)
par: Emmanuel Ssemmondo, et autres
Publié: (2024)
Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
par: Pareeta Kotecha, et autres
Publié: (2024)
par: Pareeta Kotecha, et autres
Publié: (2024)
Could continuous subcutaneous glucose sensors ( CGMS ) be repurposed to diagnose diabetes in equivocal or challenging cases?
par: Martin B. Whyte, et autres
Publié: (2025)
par: Martin B. Whyte, et autres
Publié: (2025)
Commonly used C‐peptide assays show differing associations with CGM metrics
par: Catriona Clarke, et autres
Publié: (2025)
par: Catriona Clarke, et autres
Publié: (2025)
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
par: Nathaniel Foo, et autres
Publié: (2025)
par: Nathaniel Foo, et autres
Publié: (2025)
Documents similaires
-
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘ eCGM ’ compliance status
par: Chantal Mathieu, et autres
Publié: (2024) -
Comment to ‘Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—“ eCGM ”’
par: Ohad Cohen, et autres
Publié: (2025) -
Proposed minimum requirements for market approval of continuous glucose monitoring ( CGM ) systems: A viewpoint from the IFCC working group on CGM
par: Stefan Pleus, et autres
Publié: (2025) -
Contributions of intermittently scanned continuous glucose monitoring frequency and bolus insulin dosing on time in range: Analysis of data from CGM and connected insulin pens
par: Pratik Choudhary, et autres
Publié: (2025) -
Diabetes screening in dialysis populations with a glucose challenge test and continuous glucose monitoring— DIGEST study
par: L. Depoorter, et autres
Publié: (2025)